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dysfunction & stunning, independent of coronary collaterals and metabolic substrate.
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Pathological ﬁndings of basophilic foreign materials in 10 coronary artery and 3
intracerebral Pipeline cases
Kazuyuki Yahagi1, Fumiyuki Otsuka1, Kenichi Sakakura1, Elena Ladich1,
Frank D. Kolodgie1, Renu Virmani1
1CVPath Institute, Inc., Gaithersburg, MD
Background: Today percutaneous intervention is the preferred treatment for athero-
sclerotic disease in any part of the body, therefore there is a greater potential for
embolization of material used on such devices. Several reports have shown that
foreign materials such as the hydrophilic polymer can induce obstruction of small
vessels with distal necrosis as well as granulomatous hypersensitivity reaction
(Modern Pathology 2010; 23:921-30).
Methods: We reviewed autopsy registry ﬁles from 2005 to 2013 and identiﬁed 13
cases of foreign body hydrophilic polymer that was associated with untoward effects.
Results: There were 10 coronary (total stents ¼ 29) and 3 intracerebral interventions
that at autopsy had foreign materials identiﬁed around the stent strut or in the distal
bed. Overlapping stent were used in 6 cases (60%) and mean stented lesion length was
2718mm in the coronary artery cases. All showed the presence of foreign body
basophilic materials in the intramural small coronary artery with or without chronic
inﬂammation, ﬁbrin and giant cells. Foreign body basophilic materials were observed
around stent struts in 3 cases. Basophilic materials were identiﬁed in the left ventricle
in 6 cases (60%), right ventricle in 3 cases (30%) and in both ventricle in 1 case (10%).
Most of the basophilic materials were seen in the epicardial one third of the ventricle
with or without myocyte necrosis. The 3 intracerebral cases involved the internal
carotid artery in 2 and the basilar artery in 1, all had Pipeline stent implantation and in
2 cases embolic material was identiﬁed in the area of the intracerebral hemorrhage
and/or in surrounding brain sections with or without inﬂammation. All 3 Pipeline
stents in the artery showed basophilic material on histologic examination. In some
cases the basophilic material was identiﬁed to be hydrogel on spectroscopic
examination.
Conclusions: Hydrogel polymers are commonly used on interventional devises for
improvement of deliverability. However, unexpectable embolization of basophilic
hydrogel was identiﬁed in all 13 cases. Hydrogel is not a benign material and its use in
its current form on devices should be changed.
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The Paclitaxel-coated balloon catheter presents a therapeutic alternative in select
coronary indications – Results of an analysis of the raw data of 7 prospective
studies
Martin Unverdorben1, Hannah Nuiding1, Christian Vallbracht2, Bruno Scheller3,
Ralf Degenhardt1
1Clinical Research Institute, Rotenburg, Germany, 2Center for Cardiovascular
Diseases, Rotenburg, Germany, 3University of Saarland, Germany, Homburg,
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Background: The paclitaxel-coated balloon catheter (DCB) based on the
PACCOCATH technology has yielded angiographic and clinical results superior to
drug-eluting stents in situations like bare-metal in-stent restenosis and a trend towards
better outcome in small coronary vessels and side branches of coronary bifurcations.
The sample size of each individual study, however, was relatively small
Methods: To strengthen the evidence, the raw data of all 401 patients (63.310.5
years, 74.3% men) with 446 stenoses that were treated with SeQuentTM Please DCB
or its predecessor in the PACCOCATH ISR I/II, PEPCAD I, II, IV, V and INDICOR
studies were analyzed. Main outcome parameters encompassed the 6-9month angio-
graphic and 1-year MACE data. The patients were categorized into the following
groups: De-novo lesions in native vessels treated with DCBonly (82Px./106 stenoses),
stenoses in native vessels treated with DCB and several types of bare-metal stents
(BMS) (DCB+BMS: 202Px. /223 stenoses) and bare-metal in-stent restenosis treated
with DCB only (BMS-ISR; 117Px./117 stenoses).
Results: DCBonly compared to BMS-ISR did not show statistically different results
for late lumen loss (LLL) (0.190.59mm vs 0.230.53mm), LLLIndex (0.150.31B102 JACC Vol 62/18/Suppl B j October 27–Novemvs 0.160.56), target lesion revascularization (TLR) (4/82 (4.9%) vs 6/117 (5.1%)),
lesion related myocardial infarction major and target lesion thrombosis (both
parameters in both groups 0), cardiac death (0/82 (0%) vs 1/117 (0.9%)), and major
adverse cardiac events (MACE) (4/82 (4.9%) vs 6/117 (5.1%)). In DCB combined
with BMS, TLR (16/202 (7.9%)), lesion related myocardial infarction (7/202 (3.5%)),
target lesion related thrombosis (5/202 (2.5%)), and cardiac death (3/202 (1.5%)) were
statistically not different compared to DCB only in de-novo lesions while in
DCB+BMS the LLL (0.550.65mm) was signiﬁcantly (p<0.001) greater as were
LLLIndex (0.340.41, p<0.001) and MACE 25/202 (12.4%) (p¼0.08). The 1-year
MACE rates were independent from gender, and the cardiovascular risk factors
smoking, hyperlipidemia, obesity, hypertension, and diabetes.
Conclusions: Angiographically, DCBonly was superior to its combination with bare
metal stents whereas MACE data trended superior.
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Impact of Diabetes Duration on Long-term Clinical Outcomes following
Coronary Revascularization: A Cohort Study From China’s Largest Cardiac
Center
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Bo Xu1, Yongjian Wu1, Yuejin Yang1, Runlin Gao1
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Background: Prior studies implicated that a longer diabetes duration might raise
coronary artery disease (CAD) risks and predict mortality. However, few studies have
addressed its predictive value in patients undergoing coronary revascularization. Thus,
we aimed to evaluate the impact of diabetes duration on long-term clinical outcomes
after primary percutaneous coronary intervention (PCI) or coronary artery bypass
grafting (CABG).
Methods: A total of 820 diabetic patients treated for stable CAD were consecutively
included in this retrospective single-center study. With a median follow-up of 3.5
years, patients’ outcomes were assessed by major adverse cardiac events (MACEs)
and the incidence of nonfatal stroke. MACEs were deﬁned as the need for revascu-
larization, non-fatal myocardial infarction, or cardiovascular death.
Results: At 3-year follow-up, MACE rate was signiﬁcantly higher in PCI- compared
with CABG-treated patients (13.30% vs. 7.02%, p¼0.001). Multivariate Cox
regression analysis revealed that a longer diabetes duration ( 5 years) was an
independent predictor for the incidence of MACEs after PCI (HR¼1.89, 95% CI 1.08-
3.30, p¼0.03), but not CABG (0.21-2.93, p¼0.73). In addition, while CABG was
superior to PCI in patients with diabetes duration  5 years (17.30% vs. 7.21%,
p¼0.003), no difference was observed in those < 5 years (9.36% vs. 6.86%, p¼0.18).
Notably, no differential treatment effect according to the category of SYNTAX score
was found in patients with diabetes duration < or  5 years (p¼0.79 and p¼0.15,
respectively). In contrast to MACEs, nonfatal stroke was more frequent in CABG-
than PCI-treated patients (4.36% vs. 1.13% p¼0.02), with no signiﬁcant interaction
between diabetes duration and treatment strategies on the outcome (p¼0.58).
Conclusions: For stable CAD patients with a longer diabetes duration ( 5 years),
CABG was superior to PCI in that it signiﬁcantly reduced rates of MACEs, despite of
a higher rate of nonfatal stroke. However, for those with a shorter diabetes duration
(< 5 years), PCI was more preferable than CABG, which was independent of the
SYNTAX stratiﬁcation, as it markedly reduced rate of nonfatal stroke without
signiﬁcantly increasing the risk of MACEs.
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Utility of the Residual SYNTAX Score In Patients With Diabetes Mellitus After
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Background: Both diabetes mellitus (DM) and incomplete revascularization (IR) are
associated with a poor prognosis after percutaneous coronary intervention (PCI). We
sought to quantify the extent and impact of IR following PCI using the residual
SYNTAX score (rSS) in patients (pts) with and without DM.
Methods: The rSS was determined by an angiographic core laboratory in 2672 pts
with moderate and high-risk acute coronary syndromes (ACS) undergoing PCI from
the ACUITY trial. Pts were stratiﬁed by rSS tertiles. A rSS¼0 was deﬁned as
complete revascularization (CR). One-year major adverse cardiovascular events
(MACE) according to rSS were examined in DM and non-DM pts.
Results: Overall, 770 (28.8%) pts had DM and 1,902 did not. The mean rSS was
4.96.6 and 4.16.5 in DM and non-DM pts respectively (p¼0.004). CR was ach-
ieved in 35.0% of DM and 42.5% of non-DM pts (p¼0.004). As rSS increased, 1-year
MACE was signiﬁcantly higher in non-DM but not DM pts (Figure). DM pts also had
higher incidence of death (3.0% vs.0.9%; p¼0.01) and MACE at 1-year (22.5% vs.
14.1%; p¼0.001) than non-DM pts, even when CR was achieved.ber 1, 2013 j TCT Abstracts/POSTER/Miscellaneous Coronary Topics
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pts with ACS, and was less frequent in DM compared to non-DM pts. Patients with
DM had higher rates of adverse outcomes compared to non-diabetics even when CR
was achieved, and the extent of IR was less of a prognostic factor in DM compared to
non-DM pts. Further strategies are required to improve the prognosis in high-risk
DM pts.
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Higher Adverse Clinical Event Rates in Young African American Women
Undergoing Percutaneous Coronary Intervention: Results from the NHLBI
Dynamic Registry
Kelly C. Epps1, Elizabeth M. Holper2, Helen Vlachos3, Faith Selzer3,
Hansie Mathelier1, Peter Groeneveld1, Robert Wilensky1
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3University of Pittsburgh, Pittsburgh, PA
Background: Prior studies suggest that younger women are at higher risk for major
adverse events following PCI; however, little is known about the association between
race and adverse outcomes in this population.
Methods: We evaluated 3797 women undergoing PCI in the NHLBI Dynamic
Registry and compared 1 year outcomes in African American (AA) women <50 years
(n¼101), AA women  50 years (n¼537), non-AA women < 50 years (n¼293), and
non-AA women  50 years (n¼2866) old.
Results: AA women were more likely to have hypertension, renal disease, and
concomitant severe non-cardiac disease compared to non-AA women. Irrespective of
race, younger women had less severe CAD angiographically. In-hospital adverse
events (death, MI, CABG, stroke) were comparable by race and age; however, young
AA women had the highest rate of MACE (young AA women: 28.6%, older AA
women: 18.4%, young non-AA women 27.6%, older non-AA women: 23.3%,
p¼0.02) at 1 year. While the rate of MI was lower (young AA women: 3.6%, older
AA women: 5.8%, young non-AA women 7.2%, older non-AA women: 5.4%,
p¼0.50), young AA women had a higher incidence of mortality than non-AA women
of similar age (young AA women: 5.8%, older AA women: 5.0%, young non-AA
women: 1.1%, older non-AA women: 5.8%, p¼0.009) at 1 year. Young women also
had higher rates of repeat revascularizations compared to older women, with young
AA women having the highest rate of CABG and young non-AA women having the
highest rate of repeat PCI at 1 year.One-Year Cumulative Event Rates for Women, By Race and Age
Follow-up
Events
(N=3797)
African
American
Age < 50
(N=101)
African
American
Age  50
(N=537)
Non-
African
American
Age <
50(N=293)
Non-African
American
Age 
50(N=2866)
p value
(comparing
all 4
groups)
% % % %
MACE1 28.6 18.4 27.6 23.3 0.03
Death 5.8 5.0 1.1 5.9 0.009
Myocardial
Infarction
3.6 5.8 7.2 5.4 0.50
Death or
Myocardial
Infarction
9.2 10.3 7.9 10.6 0.52
CABG 10.5 3.8 8.4 4.9 0.005
Repeat
PCI2
16.2 9.6 19.9 12.5 <0.001
CABG/
Repeat
PCI2
24.2 11.9 25.0 16.4 <0.001
Abbreviations MACE-major adverse cardiovascular events, CABG - coronary artery bypass graft
surgery, PCI - percutaneous coronary intervention
1Composite of death/myocardial infarction/CABG/repeat PCI
2 Excluding planned, staged PCI
JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Young AA women experienced higher rates of major adverse events
within 1 year of PCI, including a mortality rate four times higher than non-AA women
of similar age. It is plausible that our ﬁndings are due to a higher prevalence of non-
cardiac comorbidities; however, secondary prevention measures and practice patterns
post-PCI need to be explored to ensure this population is receiving optimal cardio-
vascular care following PCI.
TCT-324
Survival after percutaneous coronary intervention (PCI): Comparison of patients
with or without Left Anterior Descending stenosis in elective percutaneous
coronary intervention for left main disease and triple vessel disease
Min Zhao1, Heinz Joachim Büttner2, Michael Gick1, Franz-Josef Neumann3,
Thomas G. Nuehrenberg1, Christian M. Valina1
1Universitäts-Herzzentrum Freiburg, Bad Krozingen, Bad Krozingen, Germany,
2Heart Center Bad Krozingen, Bad Krozingen, Germany, 3Universitäts-Herzzentrum
Freiburg - Bad Krozingen, Bad Krozingen, Germany
Background: Patients with signiﬁcant left anterior descending artery (LAD) disease,
particularly when the proximal segment is involved, considered to have an adverse
cardiac prognosis. It is reported that proximal LAD stenosis (P-LAD) have higher
rates of restenosis than that in other coronary segments after angioplasty, as well as
after stenting. However, the long term results of patients with P-LAD in complex
coronary artery disease (CAD) have not yet been adequately studied. Our study aimed
to ﬁnd out if the long term mortality of patients with P-LAD among the cohort with
three vessel diseases (TVD) and/or left main stenosis (LMS) higher than that without
P-LAD.
Methods: Patients undergoing elective PCI with drug eluting stents (DES) for TVD
and/or LMS have been included in this study. Important exclusion criteria were
previous coronary artery bypass surgery, high-risk acute coronary syndrome including
myocardial infarction. All-cause death was the primary endpoint of this analysis.
Survival of the patients was assessed by systematic patient contacts at one, two and
three years. In all patients we calculated SYNTAX score (SSc) to deﬁne the anatomic
complexity of coronary artery disease and logistic EuroScore (LES) to determine the
clinical risk. We used the Kaplan-Meier method to estimate the mortality. In addition,
we calculated adjusted and unadjusted hazard ratios by Cox models.
Results: 1,262 patients (mean age 67.7310.33 years, 24% female, median SSc
21.348.47) met the entry criteria. Median follow-up was 1197465.05 days. P-LAD
was present in 364 patients (28.84%). SSc in group with P-LAD was higher
(24.698.24 vs. 208.36, p<0.01). There was no signiﬁcant difference of one, two
and three-year mortality between the group with and without P-LAD (3.00.9 % vs.
2.90.6%; 5.01.2% vs. 5.20.7; 8.01.5% vs. 8.21.0%, p¼0.67; 0.64; 0.69).
Hazard ratio for mortality in the presence of P-LAD was 1.08 (95% CI 0.76 – 1.54,
p¼0.67). Even after adjustment for SSc and LES in multivariable analysis, P-LAD
was not predictive for mortality (adjusted HR 1.34 (0.94 – 1.94), p¼0.11).
Conclusions: P-LAD as single criterion has no signiﬁcant prognostic relevance in
patients with complex CAD.
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Revascularization Heart Team Favors Percutaneous Coronary Intervention in
Patients with Intermediate and High SYNTAX when Demographic and Clinical
Predictors are Included.
Carlos E. Sanchez1, Oscar C. Marroquin2, Sameer J. Khandhar3, Joon S. Lee4,
John T. Schindler2, A. J. Conrad Smith5, Catalin Toma2, Suresh Mulukutla4
1University Of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittsburgh,
Pittsburgh, PA, 3University of Pittsburgh Medical Center, Pittsburgh, PA, 4University
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Background: Randomized controlled trials in patients with complex ischemic heart
disease (CIHD) suggest that patients with an intermediate/high SYNTAX score
beneﬁt from surgical revascularization. However its impact in decision making in
routine clinical practice is unknown. Using a multidisciplinary Heart Team (MHT) we
set out to evaluate therapeutic decision making in patients with complex IHD using
SYNTAX scores combined with Society of Thoracic Surgeons (STS)-derived clinical
variables.
Methods: MHT meetings consisting of interventional cardiologists and cardiac
surgeons were convened to discuss management of patients with CIHD. Angiographic
SYNTAX and STS risk were calculated and grouped according to risk scores Figure 1.
Final recommendations on revascularization were based on consensus that factored
angiographic and clinical characteristics
Results: 201 consecutive patients underwent MHT review. Mean(SD) STS risk
between groups showed; Group 1:1.4%(1.02), Group 2:7.4%(1.8), Group 3:1.5%(1.2)
and Group 4:9.9%(4.8) (p<0.0001). Mean(SD) SYNTAX score showed; group
1:15(4.8), Group 2:16(4.7), Group 3:29.7(6.1), and Group 4:32.4(6.1) (p<0.0001).
MHT recommendations are outlined in Tableacts/POSTER/Miscellaneous Coronary Topics B103
